---
title: "Lenvatinib - Carcinoma, Renal Cell"
sidebar: mydoc_sidebar
permalink: db09078-mesh-d002292-1.html
toc: false 
---


Path ID: `DB09078_MESH_D002292_1`
{% include image.html url="images/db09078-mesh-d002292-1.png" file="db09078-mesh-d002292-1.png" alt="db09078-mesh-d002292-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C531958">MESH:C531958 </a> | lenvatinib | Drug |
| <a href="https://identifiers.org/InterPro:IPR009135">InterPro:IPR009135 </a> | Vascular endothelial growth factor receptor 1 (VEGFR1) | GeneFamily |
| <a href="https://identifiers.org/GO:0001525">GO:0001525 </a> | angiogenesis | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D002292">MESH:D002292 </a> | Carcinoma, Renal Cell | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lenvatinib | DECREASES ACTIVITY OF | Vascular Endothelial Growth Factor Receptor 1 (Vegfr1) |
| Vascular Endothelial Growth Factor Receptor 1 (Vegfr1) | POSITIVELY REGULATES | Angiogenesis |
| Angiogenesis | CONTRIBUTES TO | Carcinoma, Renal Cell |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09078#mechanism-of-action](https://go.drugbank.com/drugs/DB09078#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Adenocarcinoma](https://en.wikipedia.org/wiki/Adenocarcinoma)
  - [https://en.wikipedia.org/wiki/Renal_cell_carcinoma](https://en.wikipedia.org/wiki/Renal_cell_carcinoma)
